Ingelheim, Germany

Michael R Linder

USPTO Granted Patents = 2 

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2022-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Michael Linder - Innovator in Animal Health

Introduction

Michael Linder is a notable inventor based in Ingelheim, Germany. He has made significant contributions to the field of veterinary medicine, particularly in the treatment of respiratory diseases in livestock. His work focuses on improving animal health and welfare through innovative solutions.

Latest Patents

Linder holds a patent for "Compounds for the treatment of bovine or swine respiratory disease." This invention provides compounds specifically designed for the treatment of respiratory diseases affecting animals, especially Bovine Respiratory Disease (BRD) and Swine Respiratory Disease (SRD). His patent represents a crucial advancement in veterinary therapeutics.

Career Highlights

Michael Linder is associated with Intervet Inc., a company known for its commitment to animal health. His role at Intervet has allowed him to leverage his expertise in developing effective treatments for livestock diseases. Linder's dedication to innovation in this field has positioned him as a key figure in veterinary medicine.

Collaborations

Throughout his career, Linder has collaborated with esteemed colleagues such as Thorsten Meyer and Ralf Warrass. These partnerships have fostered a collaborative environment that enhances the development of new solutions for animal health challenges.

Conclusion

Michael Linder's contributions to veterinary medicine through his innovative patent and collaboration with industry professionals highlight his commitment to improving animal health. His work continues to impact the treatment of respiratory diseases in livestock, showcasing the importance of innovation in this field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…